New pack size to ‘help address supply shortage’

PBAC recommends expanding empagliflozin treatment population in line with “pivotal” trial, changes to max quantities for pioglitazone and listing of new contraceptive choice in May meeting The PBAC has recommended new and updated PBS listings for multiple medicines, including a change to empagliflozin (Jardiance) to treat an expanded population of adult patients with chronic kidney